SummaryBackgroundThere are clinical and pathological factors associated with the clinical course of melanoma. These parameters allow us to predict survival times and establish a course of treatment.AimThe aim of the study was to assess the significance of immunohistochemical markers in the progression of melanoma, and relate these findings to the influence of clinical and histological factors on survival time.Materials/MethodsIn this study, archival histological material obtained from 50 melanoma patients operated on in the Great Poland Cancer Centre between 1990–1995 was analysed. Using immunohistochemistry we detected the presence of markers known to be important in the diagnosis of melanoma, including: HMB-45, PCNA, Ki-67, MMP-2, CD44 an...
Cutaneous melanoma is a heterogeneous disease affecting the regulation of multiple genes and protein...
The aim of this study was to define prognostic factors for survival, and especially for long-term su...
BACKGROUND AND OBJECTIVES: Overall survival (OS) in patients with early-stage malignant melanoma dif...
SummaryBackgroundThere are clinical and pathological factors associated with the clinical course of ...
BACKGROUND: The prognosis of cutaneous melanoma is correlated to histopathologic parameters such as ...
Stage III metastatic melanomas require adequate adjuvant immunotherapy to prevent relapses. Prognost...
International audienceStage III metastatic melanomas require adequate adjuvant immunotherapy to prev...
Introduction. Lymphatic invasion (LYI) and lymphangiogenesis in the primary tumor are important proc...
There is an urgent need to identify more accurate prognostic biomarkers in melanoma patients, partic...
Because of the failure so far to find effective treatment for patients with advanced stages of melan...
INTRODUCCIÓN. El objetivo de esta investigación fue determinar el valor pronóstico independiente y l...
The aim of the study was to explore the prognostic and predictive significance of proliferative inde...
Data on survival with mucosal melanoma and on prognostic factors of are scarce. It is still unclear ...
IntroductionAmong white people, the incidence of cutaneous malignant melanoma (CMM) has been increas...
The goal was to prove the prognostic significance of nuclear-morphometric and immunohistochemical pa...
Cutaneous melanoma is a heterogeneous disease affecting the regulation of multiple genes and protein...
The aim of this study was to define prognostic factors for survival, and especially for long-term su...
BACKGROUND AND OBJECTIVES: Overall survival (OS) in patients with early-stage malignant melanoma dif...
SummaryBackgroundThere are clinical and pathological factors associated with the clinical course of ...
BACKGROUND: The prognosis of cutaneous melanoma is correlated to histopathologic parameters such as ...
Stage III metastatic melanomas require adequate adjuvant immunotherapy to prevent relapses. Prognost...
International audienceStage III metastatic melanomas require adequate adjuvant immunotherapy to prev...
Introduction. Lymphatic invasion (LYI) and lymphangiogenesis in the primary tumor are important proc...
There is an urgent need to identify more accurate prognostic biomarkers in melanoma patients, partic...
Because of the failure so far to find effective treatment for patients with advanced stages of melan...
INTRODUCCIÓN. El objetivo de esta investigación fue determinar el valor pronóstico independiente y l...
The aim of the study was to explore the prognostic and predictive significance of proliferative inde...
Data on survival with mucosal melanoma and on prognostic factors of are scarce. It is still unclear ...
IntroductionAmong white people, the incidence of cutaneous malignant melanoma (CMM) has been increas...
The goal was to prove the prognostic significance of nuclear-morphometric and immunohistochemical pa...
Cutaneous melanoma is a heterogeneous disease affecting the regulation of multiple genes and protein...
The aim of this study was to define prognostic factors for survival, and especially for long-term su...
BACKGROUND AND OBJECTIVES: Overall survival (OS) in patients with early-stage malignant melanoma dif...